PARP1 and ovarian carcinoma: miR-519a-3p was demonstrated to suppress the growth, invasion, and migration via PARP1 in ovarian cancer [37], and miR-519a-3p served as a target of LINC01419 to repress the proliferation and metastasis of osteosarcoma cells via PDRG1 [38].